Evidence map›Paper›PMID 36811820›Full record

ReviewCurrent heart failure reports2023

Heart Failure and Multimorbidity in Asia.

Nathalie Ang, Chanchal Chandramouli, Kelvin Yiu, Claire Lawson, Jasper Tromp

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current heart failure reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nathalie AngSaw Swee Hock School of Public Health, The National University of Singapore (NUS), 12 Science Drive 2, Singapore, #10-01117549, Singapore.
Chanchal ChandramouliDuke-NUS Medical School, Singapore, Singapore.
Kelvin YiuDivision of Cardiology, Department of Medicine, The University of Hong Kong, Hong Kong, China.
Claire LawsonUniversity of Leicester, Leicester, UK.
Jasper TrompSaw Swee Hock School of Public Health, The National University of Singapore (NUS), 12 Science Drive 2, Singapore, #10-01117549, Singapore. jasper_tromp@nus.edu.sg.ORCID http://orcid.org/0000-0001-6043-0713

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of the reviewMultimorbidity, the presence of two or more comorbidities, is common in patients with heart failure (HF) and worsens clinical outcomes. In Asia, multimorbidity has become the norm rather than the exception. Therefore, we evaluated the burden and unique patterns of comorbidities in Asian patients with HF. RECENT

findingsAsian patients with HF are almost a decade younger than Western Europe and North American patients. However, over two in three patients have multimorbidity. Comorbidities usually cluster due to the close and complex links between chronic medical conditions. Elucidating these links may guide public health policies to address risk factors. In Asia, barriers in treating comorbidities at the patient, healthcare system and national level hamper preventative efforts. Asian patients with HF are younger yet have a higher burden of comorbidities than Western patients. A better understanding of the unique co-occurrence of medical conditions in Asia can improve the prevention and treatment of HF.

Indexed as

Heart FailureAsiaChronic DiseaseComorbidityDelivery of Health CareHumansMultimorbidityAsiaHeart failureMultimorbidity

Identifiers

PMID36811820
PMCPMC9977703

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.